Sponsors and FDA may have a tough time developing and approving a non-Mylan NV sanctioned generic EpiPen (epinephrine), in part because any new product might have to overcome patients' familiarity with the brand competitor.
A different device already has been shown to potentially cause confusion, which is a concern because a generic could be...








